Home/Oblique Therapeutics/Hans Peter Ostler
HP

Hans Peter Ostler

Chairman of the Board

Oblique Therapeutics

Roles

Chairman of the BoardatOblique Therapeutics
Chairman of the BoardatAlligator Bioscience
Chairman of the Boardatalligator-bioscience-ab

Therapeutic Areas

Oblique Therapeutics Pipeline

DrugIndicationPhase
Proprietary Pain Program(s)PainPre-clinical
Proprietary Oncology Program(s)Aggressive-metastatic cancerPre-clinical
Eli Lilly CollaborationUndisclosedDiscovery
Animal Health Company CollaborationVeterinary (Undisclosed)Discovery